Cargando…

Adipose-derived mesenchymal stem cells attenuate dialysis-induced peritoneal fibrosis by modulating macrophage polarization via interleukin-6

BACKGROUND: Life-long peritoneal dialysis (PD) as a renal replacement therapy is limited by peritoneal fibrosis. Previous studies showed immunomodulatory and antifibrotic effects of adipose-derived mesenchymal stem cells (ADSCs) on peritoneal fibrosis. However, the role of the peritoneal macrophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chih-Yu, Chang, Pu-Yuan, Chen, Jun-Yi, Wu, Bo-Sheng, Yang, An-Hang, Lee, Oscar Kuang-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977319/ https://www.ncbi.nlm.nih.gov/pubmed/33741073 http://dx.doi.org/10.1186/s13287-021-02270-4

Ejemplares similares

Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis
por: Yang, Chih-Yu, et al.
Publicado: (2017)

Shorter daily dwelling time in peritoneal dialysis attenuates the epithelial-to-mesenchymal transition of mesothelial cells
por: Lee, Yi-Che, et al.
Publicado: (2014)

Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
por: Li, Fang, et al.
Publicado: (2022)

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis
por: Wang, Jie, et al.
Publicado: (2013)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Li, Yi-Chen, et al.
Publicado: (2021)

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation
por: Lu, Jing, et al.
Publicado: (2023)

The Gut-Peritoneum Axis in Peritoneal Dialysis and Peritoneal Fibrosis
por: Stepanova, Natalia
Publicado: (2023)

The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis
por: Sung, Su Ah, et al.
Publicado: (2019)

Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis
por: Masola, Valentina, et al.
Publicado: (2022)

Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes
por: Liao, Chia-Te, et al.
Publicado: (2017)

Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition
por: Wang, Jun, et al.
Publicado: (2017)

Macrophage polarization in tissue fibrosis
por: Yang, Huidan, et al.
Publicado: (2023)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
por: Nasir, Ghazanfar Ali, et al.
Publicado: (2013)

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022)

Protection of the Peritoneal Membrane by Peritoneal Dialysis Effluent-Derived Mesenchymal Stromal Cells in a Rat Model of Chronic Peritoneal Dialysis
por: Zhou, Lan, et al.
Publicado: (2019)

Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial‐to‐mesenchymal transition, inflammation and angiogenesis
por: Liu, Feng, et al.
Publicado: (2021)

Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
por: Zhou, Xun, et al.
Publicado: (2023)

New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis
por: Witowski, Janusz, et al.
Publicado: (2015)

A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis
por: Li, Jin’e, et al.
Publicado: (2023)

Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients
por: Hsu, Heng-Jung, et al.
Publicado: (2018)

Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety
por: Alatab, Sudabeh, et al.
Publicado: (2019)

Adipose-Derived Mesenchymal Stem Cells Modulate Fibrosis and Inflammation in the Peritoneal Fibrosis Model Developed in Uremic Rats
por: Costalonga, Elerson C., et al.
Publicado: (2020)

Mechanisms of Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells During Peritoneal Dialysis
por: Lee, Hi Bahl, et al.
Publicado: (2007)

The influence of seasonal factors on the incidence of peritoneal dialysis-associated peritonitis
por: Zeng, Ying, et al.
Publicado: (2020)

RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis
por: Wang, Qinglian, et al.
Publicado: (2018)

Crucial Role of NLRP3 Inflammasome in the Development of Peritoneal Dialysis-related Peritoneal Fibrosis
por: Hishida, Erika, et al.
Publicado: (2019)

Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis
por: Nam, Bo Young, et al.
Publicado: (2017)

The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis
por: Miao, Chusheng, et al.
Publicado: (2020)

Current Insights into Cellular Determinants of Peritoneal Fibrosis in Peritoneal Dialysis: A Narrative Review
por: Suryantoro, Satriyo Dwi, et al.
Publicado: (2023)

Protective effects and mechanisms of omega‐3 polyunsaturated fatty acid on intestinal injury and macrophage polarization in peritoneal dialysis rats
por: Tang, Hanfen, et al.
Publicado: (2019)

Prophylactic Antibiotics for Endoscopy-Associated Peritonitis in Peritoneal Dialysis Patients
por: Wu, Hsin-Hsu, et al.
Publicado: (2013)

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients
por: Cho, Yeoungjee, et al.
Publicado: (2014)

Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis
por: Loureiro, Jesús, et al.
Publicado: (2013)

The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage
por: Lee, Yi-Che, et al.
Publicado: (2019)

Citrobacter Peritoneal Dialysis Peritonitis: Rare Occurrence with Poor Outcomes
por: Chao, Chia-Ter, et al.
Publicado: (2013)

Mesenchymal stroma cells in peritoneal dialysis effluents from patients
por: Liu, Bin, et al.
Publicado: (2017)

Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis
por: Wen, Jun-Hao, et al.
Publicado: (2022)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Adipose-Derived Stromal Cells Attenuate Adipose Inflammation in Obesity through Adipocyte Browning and Polarization of M2 Macrophages
por: Zhang, Wen-Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vcm71mdgptsrs8famv3qttm96u